Medical News

RSS
Chronic granulomatous disease (CGD) research: an interview with Dr. Griffin Rodgers, NIDDK director

Chronic granulomatous disease (CGD) research: an interview with Dr. Griffin Rodgers, NIDDK director

Implantation rate of CIEDs continues to rise in most European countries

Implantation rate of CIEDs continues to rise in most European countries

Viralytics releases financial results for 2013

Viralytics releases financial results for 2013

BME introduces new, improved Speed Continuous Active Compression System

BME introduces new, improved Speed Continuous Active Compression System

Sanomedics completes acquisition of Prime Time Medical

Sanomedics completes acquisition of Prime Time Medical

Sigma Life Science signs license agreement with Horizon Discovery for CompoZr ZFN technology

Sigma Life Science signs license agreement with Horizon Discovery for CompoZr ZFN technology

First Edition: September 3, 2013

First Edition: September 3, 2013

Apitope successfully completes ATX-MS-1467 Phase I trial in relapsing MS patients with positive results

Apitope successfully completes ATX-MS-1467 Phase I trial in relapsing MS patients with positive results

Prana's PBT2 drug recognised as one of the most promising treatments under development

Prana's PBT2 drug recognised as one of the most promising treatments under development

Imaxio's pro-immunogenic technology used in tuberculosis vaccine phase I clinical study

Imaxio's pro-immunogenic technology used in tuberculosis vaccine phase I clinical study

New NPS MedicineWise educational program highlights medicine-related adverse events in older people

New NPS MedicineWise educational program highlights medicine-related adverse events in older people

Renin inhibitor aliskiren not effective in slowing progression of coronary atherosclerosis

Renin inhibitor aliskiren not effective in slowing progression of coronary atherosclerosis

The Learning Habit Study examines family routines and child's ability to learn

The Learning Habit Study examines family routines and child's ability to learn

Elsevier publishes position statement by EMAS in journal Maturitas on the topic of late parenthood

Elsevier publishes position statement by EMAS in journal Maturitas on the topic of late parenthood

Research shows how mucosal surfaces in body respond to C. albicans to prevent damage

Research shows how mucosal surfaces in body respond to C. albicans to prevent damage

Trypophobia: The most common phobia may occur as result of specific visual feature

Trypophobia: The most common phobia may occur as result of specific visual feature

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.